University Hospital Heidelberg (UKHD)

What University Hospital Heidelberg (UKHD) does

University Hospital Heidelberg (Universitätsklinikum Heidelberg, UKHD) is a publicly-owned academic medical center located in Heidelberg, Baden-Württemberg, Germany. Legally constituted as an "Anstalt öffentlichen Rechts" (public-law institution) under the supervision of the Ministry for Science, Research and Art of Baden-Württemberg, UKHD operates 2,599 inpatient beds, 7 specialized medical centers, 50 medical departments, and 11 medical-theoretical institutes, supported by approximately 13,849 staff (including 3,413 nursing personnel and 2,161 medical doctors). Its service portfolio spans comprehensive inpatient, outpatient, and emergency care across all major specialties, with nationally designated centers of excellence in oncology (NCT Heidelberg) and pediatric oncology (Hopp-Kindertumorzentrum Heidelberg / KiTZ), plus specialized infrastructure such as the Heidelberger Ionenstrahl-Therapiezentrum (HIT) for particle therapy and the Zentrum für Personalisierte Medizin (ZPM) for personalized medicine.

The business model combines three revenue streams: regulated patient care reimbursed under Germany's statutory (GKV) and private (PKV) health insurance systems via DRG- and EBM-based pricing, third-party research funding from agencies including the Deutsche Forschungsgemeinschaft (DFG), federal ministries, and foundations such as the Dietmar Hopp Stiftung, and medical education revenue linked to the Heidelberg University Medical Faculty. Non-clinical operations are executed through 14 wholly-owned subsidiaries, including Klinik Service GmbH (catering, sterilization, laundry, logistics), Klinik Technik GmbH (technical services), and Klinik-Energieversorgungs-Service Gesellschaft (energy supply). Go-to-market is direct-to-patient, with a dedicated Medical International Office supporting a global medical-tourism channel on a quote-based pricing basis, while domestic distribution relies on the GKV/PKV reimbursement infrastructure.

Strategically, UKHD is anchored in a dense ecosystem of partnerships: it is a member of the Netzwerk Universitätsmedizin (NUM), a federally funded coordination network of all 36 German university hospitals, and is affiliated with four German Centers for Health Research (DZG) — DZD (diabetes), DZHK (cardiovascular), DZIF (infectious disease), and DZL (lung). It is also a core node of the Health + Life Science Alliance Heidelberg Mannheim regional consortium. Research output includes high-profile clinical milestones such as the publication of a PRAME-specific T-cell therapy case in the New England Journal of Medicine. AI and computational capabilities are institutionally embedded through the Institute for Computational Biomedicine, the Institute for Medical Informatics, and the Institute for Medical Biometry, though no commercial AI product surface is disclosed. Revenue is not publicly disclosed; the hospital is not listed on any exchange and has no external shareholders.

Name

University Hospital Heidelberg (UKHD)

Legal name

Universitätsklinikum Heidelberg

Website

https://klinikum.uni-heidelberg.de

Company type

Public

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

University Hospital Heidelberg (UKHD) is a state-owned public university hospital in Baden-Württemberg, Germany, with 13,849 staff, 2,599 beds, and 50 medical departments, delivering comprehensive inpatient and outpatient care, clinical research, and medical education, anchored by nationally designated oncology and pediatric oncology centers.

Ownership category

akta.pro rank

Product category

Academic Healthcare Services

NAICS

General Medical and Surgical Hospitals (62211), Medical Laboratories (621511)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA), Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• University hospital care
• Clinical research services
• Medical education
• Oncology treatment
• Pediatric oncology

Headquarters

HQ city

Heidelberg, Baden-Württemberg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Patient Care Services: Revenue from providing medical services to patients through the German healthcare system (GKV/PKV), including inpatient and outpatient treatments, emergency care, and specialized medical procedures
2. Research Funding and Grants: Third-party funding from Deutsche Forschungsgemeinschaft (DFG), federal ministries, and foundations such as Dietmar Hopp Stiftung for clinical research projects
3. Medical Education: Revenue from medical education and training programs affiliated with Heidelberg University Medical Faculty

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

University Hospital Heidelberg (UKHD) is a public-law university hospital that provides comprehensive inpatient and outpatient medical care across all major specialties, integrates clinical research and medical teaching, and operates highly specialized centers such as the National Center for Tumor Diseases (NCT Heidelberg), the Hopp Children's Cancer Center Heidelberg (KiTZ), the Heidelberg Ion Beam Therapy Center (HIT), and the Center for Personalized Medicine Heidelberg (ZPM).

Product overview

Universitätsklinikum Heidelberg (UKHD) is a leading university medical center comprising multiple specialized clinics, institutes, and interdisciplinary centers. The core offering is comprehensive healthcare services combined with medical research and teaching. Key specialized offerings include the National Cancer Center (NCT) Heidelberg, the Hopp Children's Tumor Center (KiTZ), and the Center for Personalized Medicine (ZPM). Supporting services are provided through subsidiaries like Klinik Service GmbH for infrastructure operations. The portfolio is organized around medical specialties (anesthesiology, surgery, radiology, neurology, etc.) and disease-specific centers (cancer, cardiovascular, diabetes, etc.), rather than a unified software product architecture.

Differentiator

Problem solved

Functional benefit

Brands

• Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg: One of Germany's leading oncological centers of excellence
• Hopp-Kindertumorzentrum Heidelberg (KiTZ)
• Health + Life Science Alliance Heidelberg Mannheim

Products and services

• National Center for Tumor Diseases Heidelberg (NCT) A specialized translational oncology center that delivers innovative cancer diagnosis and treatment while conducting clinical trials; aimed at adult and pediatric cancer patients and referring physicians.
• Hopp Children's Cancer Center Heidelberg (KiTZ) A dedicated pediatric oncology program that combines clinical care and translational research for children and adolescents with cancer and hematologic diseases.
• Heidelberg Ion Beam Therapy Center (HIT) A clinical facility providing proton and carbon ion beam radiotherapy for patients with otherwise difficult-to-treat tumors, combining treatment with clinical research.
• Center for Personalized Medicine Heidelberg (ZPM) A center that uses genomic, molecular, and clinical data to deliver individualized diagnostic and therapeutic pathways for patients with complex diseases.
• International Patient Office A coordination service for patients from outside Germany that handles treatment planning, cost estimates, visa support, and on-site logistics.

Quantifiable outcome

• Successful PRAME-specific T-cell therapy treatment published in New England Journal of Medicine
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and major.

• Health + Life Science Alliance Heidelberg MannheimcoreStrategic or Co-development PartnerMajor regional partnership connecting life sciences and medicine in the Rhein-Neckar region, driving innovation in research, patient care, and health economy. Represents massive leap in collaborative research infrastructure.
• Netzwerk Universitätsmedizin (NUM)coreStrategic or Co-development PartnerNational research network of all 36 German university hospitals, coordinated by Charité Berlin, funded by BMBF for pandemic preparedness and research coordination
• Nationales Centrum für Tumorerkrankungen (NCT) HeidelbergcoreStrategic or Co-development PartnerLeading oncological center in Germany, combining research and patient care for comprehensive cancer treatment
• Hopp-Kindertumorzentrum Heidelberg (KiTZ)coreStrategic or Co-development PartnerPediatric tumor center focused on childhood cancer research and treatment, funded by Dietmar Hopp Stiftung with approximately 1.8 million euros for T-cell therapy clinical study
• Deutsches Zentrum für Diabetesforschung (DZD)majorStrategic or Co-development PartnerGerman Diabetes Research Center - one of the German National Centers for Health Research (DZG)
• Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)majorStrategic or Co-development PartnerGerman Center for Cardiovascular Research - DZG partnership focusing on cardiovascular disease research
• Deutsches Zentrum für Infektionsforschung (DZIF)majorStrategic or Co-development PartnerGerman Center for Infection Research - DZG partnership for infectious disease research
• Deutsches Zentrum für Lungenforschung (DZL)majorStrategic or Co-development PartnerGerman Center for Lung Research - DZG partnership for pulmonary disease research

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Universitätsklinikum Köln: Large public university hospital in North Rhine-Westphalia operating the same academic-medical-center model with similar specialty centers and DZG participation.
• Universitätsklinikum Würzburg: Bavarian university hospital of comparable profile and scale; relevant peer for benchmarking specialty mix, research output, and public funding dynamics.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Northern Germany's flagship university hospital with comparable bed count, comprehensive specialty coverage, and integrated research-teaching-care model under public ownership.
• Universitätsklinikum Erlangen: Friedrich-Alexander-Universität affiliated university hospital; directly comparable full-service academic medical center in the German university hospital peer group.
• Universitätsklinikum Tübingen: Baden-Württemberg peer university hospital with strong oncology, neurology, and rare disease programs; directly comparable in size, public-institution status, and DZG research footprint.
• Universitätsklinikum Freiburg: Another Baden-Württemberg peer with comparable size and academic structure; competes with UKHD for state-level research funding, patients, and academic recruitment.
• Universitätsklinikum Münster (UKM): West German public university hospital with similar scope and academic structure; competes in the same NUM network and overlapping DZG research areas.
• Klinikum der Universität München (LMU Klinikum): Major LMU-affiliated university hospital in Munich offering the same comprehensive mix of specialty inpatient care, translational research, and medical teaching that defines UKHD.
• Charité – Universitätsmedizin Berlin: Germany's largest university hospital and the coordinator of the national Netzwerk Universitätsmedizin (NUM) network. Directly comparable as a public German academic medical center with comparable breadth, research intensity, and DZG participation.

Regional players

• Universitätsspital Zürich (USZ): Switzerland's largest university hospital — a DACH-region peer with comparable academic-medical-center model, strong oncology/translational research, and growing international patient services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/universit%C3%A4tsklinikum-heidelberg-ukhd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Hospital Heidelberg (UKHD)